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Abstract
Cells cultured in three dimensional (3D) scaffolds as opposed to traditional two-dimensional (2D) substrates have been
considered more physiologically relevant based on their superior ability to emulate the in vivo environment. Combined with
stem cell technology, 3D cell cultures can provide a promising alternative for use in cell-based assays or biosensors in non-
clinical drug discovery studies. To advance 3D culture technology, a case has been made for identifying and validating
three-dimensionality biomarkers. With this goal in mind, we conducted a transcriptomic expression comparison among
neural progenitor cells cultured on 2D substrates, 3D porous polystyrene scaffolds, and as 3D neurospheres (in vivo
surrogate). Up-regulation of cytokines as a group in 3D and neurospheres was observed. A group of 13 cytokines were
commonly up-regulated in cells cultured in polystyrene scaffolds and neurospheres, suggesting potential for any or a
combination from this list to serve as three-dimensionality biomarkers. These results are supportive of further cytokine
identification and validation studies with cells from non-neural tissue.
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Introduction
Providing a 3D spatial microenvironment for cells to grow in, is
the sole criterion that has traditionally been associated with three-
dimensional cell culture. However, with recent advances in the
field in the past decade, the meaning of 3D cell culture has been
extended to providing the ‘‘total microenvironment’’ that supports
the formation of microtissue that exhibits ‘‘complex’’ physiological
relevance (CPR) or better emulation of the in vivo functionality in
a manner not possible in 2D cultures [1]. Three main categories or
microenvironment factors (MEFs) or ‘‘three-dimensions’’ from the
literature include: 1) chemical or biochemical composition, 2)
spatial (geometric 3D) and temporal dimensions, and 3) force and
substrate physical properties [1–4]. However, there is still a lack of
a quantifiable entity which can establish if the cellular response in
a 3D culture is actually physiologically relevant and in vivo-like or
just different from 2D. The identification and validation for this
entity or a potential three-dimensionality biomarker is necessary
due to three compelling reasons. First, apart from the concept of
‘‘three-dimensional matrix adhesion’’ originally proposed by
Cukierman et al. [5] as a possible indication or ‘‘diagnosis’’ or
marker for a culture state of three-dimensionality, the fields of
tissue engineering and/or cell-based biosensors have not provided
knowledge on the basis of which a consensus for three-
dimensionality and the associated complex physiological relevance
could be established. Because of this, claims of ‘‘physiologically
more relevant’’ are readily made for cells cultured on any surface
or scaffold that provides loosely defined 3D geometry, either at the
nano- or micro- structure levels or their combinations, as long as
the resulting cell phenotypes are different between the 2D and 3D
geometries. Second, the concept of using combinatorial approach-
es to fabricate libraries of polymers or other material scaffolds [6,7]
for tissue engineering or cell-based drug discovery call for high
throughput assay by which ‘‘hit materials’’ can be quickly
identified for further development. Cell-material interaction
outcome can potentially guide the development of such assays or
biosensors [8]. An interaction with a material which yields cells
that emulate in vivo conditions would be most desirable. Three-
dimensionality biomarkers would provide the intellectual basis for
material discovery platform development. Third, in order to lower
the costs associated with 3D platforms and make them more
accessible for high throughput screening (HTS) applications,
simplification of the platform without giving up the physiologically
relevant behavior of the cells is necessary, as discussed in detail by
Lai et al. [4].
Taken together, the subfield or field of 3D culture needs
ubiquitous validated biomarkers. As a first step, in search for three-
dimensionality biomarkers, we initiated a cytokine expression
comparative transcriptomic study with neural progenitor (NP) cells
grown on 2D flat surfaces, 3D polymeric scaffolds and as
neurospheres (NS). NS were used as the in vivo surrogate, since
they have been shown to emulate many in vivo functions that have
not been possible in 2D cultures [9,10]. Cytokines are involved in
many crucial cell functions like innate and adaptive inflammatory
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and development and repair processes [11]. Based on the
structural homologies of their receptors they can be broadly
classified into families like Colony Stimulating Factors, Interleu-
kins, Interferons, TGF (transforming growth factor) family, TNF
(tumor necrosis factor) superfamily, PDGF (platelet-derived
growth factor) family and Chemokines [11]. Although cytokines
have been extensively studied in the field of immunology and
oncology, tissue or cell-based biosensor engineers have paid little
attention to these small proteins that have potential to revolution-
ize the field. The evidence for their existence in 3D cultures is
compelling but they have not yet been looked at as candidates for
potential 3D biomarkers. However, they were an ideal family to
explore for the search. The rationale behind their choice was
based on the fact that, in a 3D microenvironment cells are
surrounded by homotypic neighbors forming a loosely bound
disorganized aggregate. When compared to in vivo, such a
scenario exists only during avascular tumorogenesis or early stages
of inflammatory wound healing and both these phenomenon are
regulated by the same molecules – Cytokines [12]. So in vitro, the
cells growing in 3D relate to any of those two models depending
upon their type – malignant or primary, respectively, and
therefore upregulation of their cytokine levels was physiologically
relevant.
Materials and Methods
2.1 Materials and reagents
Neural progenitor cells were obtained from Regenerative
Bioscience Center at University of Georgia as well as Millipore
(ENStem-A
TM, Billerica, MA). Polystyrene, chloroform, ammoni-
um bicarbonate were obtained from Sigma (St. Louis, MO).
Neural basal media, penicillin/streptomycin, L-glutamine, recom-
binant human leukemia inhibitory factor (hLIF), basic fibroblast
growth factor (bFGF), B-27 supplement and phosphate buffered
saline (PBS) were obtained from Gibco (Gaithersburg, MD).
RNeasy mini kit was obtained from Qiagen (Valencia, CA).
Human Genome U133 plus 2.0 microarray chips were obtained
from Affymetrix (Santa Clara, CA).
2.2 Scaffold fabrication and neural progenitor cell culture
The scaffold fabrication process in Cheng et al. [13] was
followed. Briefly, a viscous polymer solution was prepared by
dissolving polystyrene (PS) in chloroform. Sieved ammonium
bicarbonate particles in the range of 40–60 mm were added to the
polymer solution and mixed thoroughly. These particles generated
larger scaffold pore sizes from 60–100 mm, probably due to
particle agglomeration. The paste mixture of polymer/salt/solvent
was cast into the wells of a standard glass cell culture vessel. The
optimal polymer/salt/solvent ratio of 1:20:5 (w/w/v) as deter-
mined in Cheng et al. [13] was used to generate the paste mixture.
Casting was followed by chloroform evaporation, vacuum drying,
and baking at 80uC overnight. Before use for cell culture, the
scaffolds were sterilized by immersing in 70% alcohol overnight.
PS scaffolds offer advantages of low cost, transparency for optical
detection, and/or compatibility with existing instrumentation
platforms in High Throughput Screening (HTS) applications.
Human neural stem cells or neural progenitors (NP) were
maintained in neural basal media (Invitrogen, PA) supplemented
with penicillin/streptomycin, L-glutamine, recombinant human
leukemia inhibitory factor (hLIF), bFGF and B-27, at 37uCi na
5% CO2 humidified incubator. Medium was half changed every
48 hours. For differentiation, cells were allowed to grow until 90%
confluent, after which they were exposed to differentiation
medium which was half changed every 24 hours. The composition
of differentiation medium was similar to the subculture medium
described above with the exception of bFGF. For subculturing,
90% confluent cells were aspirated by pipetting and the subculture
ratio was typically 1:2 to 1:3. Before cell seeding, both the 3D
scaffolds and 2D substrates were coated with poly-ornithine and
laminin to rule out any differences that may be caused by the
polymer material itself. Neurospheres (NS) were formed by plating
cells into non-coated dishes with shaking. Dishes without coating
and shaking prevented NP cells from attaching to the surface and
encourage them to attach to each other and form spheroid
structures. The cell seeding density was 50,000 cells/cm
2 for both
2D and 3D cultures.
2.3 Microarray gene expression analysis
Total RNA was isolated from all samples using Qiagen RNeasy
Kits (Qiagen, Valencia, CA) according to the manufacturer’s
standard protocol. The quantity of mRNA isolated from each
sample was determined using absorption at 260 and 280 nm. The
purity of each sample was monitored using the A260/A280 ratio as
well as housekeeping genes. A ratio of 1.8–2.1 was considered a
‘‘clean’’ sample and could be used in microarray experiments.
Samples were sent to Affymetrix Core facility at Medical College
of Georgia (MCG) for Human Whole Genome U133 plus 2.0
GeneChip Expression Analysis (Affymetrix, Santa Clara, CA). The
expression data is publicly available on the GEO site as Series
GSE13715.
The expression value of each gene was obtained by Expression
Console (Affymetrix) with the RMA (Robust Multiple-array
Average) algorithm. RMA is an algorithm widely applied to
create expression values for Affymetrix data. The raw intensity
values from Affymetrix genechips are background corrected, log2
transformed and then quartile normalized before a linear model
was fit to obtain an expression measure for each probe set.
2.4 Statistical analysis
Linear discriminant analysis (LDA) with cross-validation was
fulfilled by SAS DISCRIM procedure. Student t-test was used to
compare the mean expression from two conditions (2D vs. 3D and
2D vs. NS) with significance level of 0.05. To determine whether
cytokines as a group were significantly regulated by culture
condition (i.e., 2D, 3D and NS), the permutation t-test method
[14] was utilized.
Results
The development of stem cell-based, HTS compatible, in vivo
tissue-emulating biosensor platform requires a substrate or scaffold
that is not only easy to fabricate but also provides stem cells with a
3D micro environment. For this purpose, 3D porous scaffolds were
prepared from polystyrene (PS), a polymer material that has been
widely applied in fabricating cell culture vessels. The physical and
chemical properties of the scaffolds used in this study have been
described by Cheng et al. [13]. Mouse superior cervical ganglion
(SCG) and NP cells cultured in these scaffolds, and NP cells
cultured as neurospheres (spheroids) have exhibited similar
responses as freshly dissected SCG tissue in terms of voltage gated
calcium channel and resting membrane potential, while 2D
cultured cells exhibited significantly higher responses [13]. Based
on Tuj staining (neuronal marker) the neural progenitor cells in
scaffolds and neurospheres differentiated into nerve cells [15].
Additionally, spheroids have successfully emulated in vivo drug
resistance [9], providing rationale for use of the neurospheres as an
in vivo surrogate.
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Five experimental groups, with four biological replicates each,
were chosen for this study. The five experimental groups were: 1)
NP cells before differentiation induction cultured on 2D culture
vessel (B2D), 2) NP cells before differentiation in 3D scaffolds
(B3D), 3) one week culture of NP cells after differentiation
induction on 2D surfaces (A2D), 4) one week culture of NP cells
after differentiation in 3D scaffolds (A3D), and 5) neurospheres
(NS). In order to minimize the cell passage and other
environmental effects on cells, the samples were generated in
2D–3D paired manner, which means at least one 2D and one 3D
sample were generated at the same time and from the same batch
of cells. Intensity results of the transcripts were examined and
normalized to exclude background signals and reported in
arbitrary units using RMA (Robust Multiple-array Average)
algorithm. RMA is an algorithm widely applied to create
expression values for Affymetrix genechip data. The raw intensity
values from Affymetrix genechips were first background corrected,
log2 transformed and then quartile normalized. The final
expression measure was obtained by fitting a linear model for
each probe set on each array.
Before we analyze the expression data, quality control tests were
performed. No array results were accepted if the correlation
coefficient (R
2 value) between replicates was less than 0.95.
Overall, samples exhibited good correlations with each other.
Differentiation status and culture vessel difference didn’t affect the
overall gene expression pattern (Figure 1, top). We also examined
the overall pattern of gene expression based on signal intensity
box-plot (Figure 1, bottom). As is the case in box-plot data
presentations, the lowest bar represents the observed sample
minimum, the base of the box represents the lower quartile while
the top represents the upper quartile, the bar inside the box
represents the median, and the top bar represents the highest
sample observation. The box-plot displays differences between
populations without making any assumptions of the underlying
statistical distribution. With the exception of a few samples, most
of the five values represented in all the data sets (Figure 1, bottom),
are in agreement. The third sample from B3D group (B3D_3)
exhibited a very distinctive distribution of the expression value in
which it had the lowest sample maximum and the smallest
‘‘distance’’ between upper quartile and lower quartile and had a
very low correlation with other samples grown under similar
conditions, as shown in Figure 1 (top). In order for array data to be
accepted for analysis, the overall gene expression pattern has to be
similar with no wide divergence between samples. Large variations
indicate either hybridization errors or problems with the quality of
the RNA used. For this reason B3D_3 was excluded from further
analysis. Also, the third sample from A3D group had overall low
expression values and a noticeable shift in intensity histogram
(data not shown). It had a low correlation coefficient with sample
Figure 1. Microarray data quality. The quality of the microarray data was accessed by Pearson’s correlation of the samples and the overall
distribution of the mRNA expression. The upper panel shows the Pearson’s correlation for each pair of the samples. B2D indicate the samples from
‘‘Before differentiation, 2D culture condition’’, A2D ‘‘After differentiation, 2D culture’’, B3D ‘‘Before differentiation, 3D culture’’, A3D ‘‘After
differentiation, 3D culture’’, and NS ‘‘Neurospheres’’. Pearson’s correlation coefficient is a widely used similarity measure for gene expression data. It
measures the similarity between two profiles by calculating the linear relationship of the distributions of the two corresponding random variables.
The Pearson’s correlation value is indicated the color bar color scale (values close to 1 indicate good correlation). The lower panel shows the box-plot
of each sample. The box shows the range of the middle 50% with a line in the center for the median value. Additional lines indicate the overall range
of the data.
doi:10.1371/journal.pone.0026821.g001
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excluded from further analysis.
3.2 Cytokines’ transcript and culture classification
The focus on cytokines in this study was based on previous
proteomic and transcriptomic evidences from other 3D culture
studies indicating that cytokines’ expression levels are altered by
culture conditions [16–19]. The list of cytokines analyzed was
obtained from the Immunology Database and Analysis Portal
(ImmPort) (https://www.immport.org/immportWeb/queryref/
geneListSummary.do). There were a total of 681 probesets found
in our microarray corresponding to the list of human cytokines.
The permutation method was used to determine whether
cytokines as a group was significantly regulated by culture
conditions (i.e. 2D and 3D). Although we reduced the number
of probesets to be analyzed from the genechip total of 54000 to
681, by focusing only on cytokines, the number of variables
(transcript expression level in our case) still greatly exceeded the
number of samples. Permutation testing is superior to standard
tools for estimating statistical significance for multiple hypotheses
testing due to its ability to empirically determine whether the
observed class distinction could be obtained by chance. Briefly, the
assay samples were re-iteratively reassigned randomly to the
classification label (2D, 3D or NS). This process was done by
randomly sampling function from R console’s base package. After
each reiteration, a list of p values were calculated measuring the
significance of newly designated culture condition label for each
probesets (2D vs. 3D or 2D vs. NS). After 1000 permutations,
summary statistics (we used the median p value) with the permuted
class distinction were generated and compared to those obtained
in the experimental data [14,20]. Results showed that cytokines as
a group was significant when comparing 2D with 3D or NS (at a
significance level of 0.05).
Next, we used linear discriminant analysis (LDA) to test if
cytokine transcriptomic expressions can form a good criterion to
separate 2D samples from 3D samples. LDA is a multivariate
statistical technique commonly used to build a linear prescriptive
or descriptive model which can characterize or classify each
observation into two or more groups. LDA is also commonly used
as a dimension reduction method for further classification analysis.
Compared to cluster analysis such as Principle Component
Analysis (PCA), LDA requires prior knowledge of the classes,
which fitted our purpose of study.
The LDA results are presented in Table 1. As shown cytokines
successfully classified 2D from 3D samples with acceptable low
error counts. After-differentiation had a lower error rate in
comparison to before-differentiation condition. This indicated that
if 3D biomarker cytokines do exist, they may be culture time
dependent. As pointed out by Lai et al. [4], under such
circumstances biomarking with a profile as opposed to an end-
point measurement would be the most practical and would
increase the robustness of the biomarker. NS exhibited 0 error
classification count, suggesting that it was more different from all
other culture conditions.
In Table 2 we list 16 cytokines selected by stepwise discriminant
analysis with a cut off p-value of 0.01. With these 16 cytokines, the
classification of 2D, 3D and NS is achieved with 0 error rate after
cross-validation. Ten of these cytokines are commonly up-
regulated in both 3D and NS culture conditions (however not
statistically significant). Two are down-regulated both in 3D and
NS. Although statistically these cytokines can discriminate 2D
from 3D effectively, they are not as a group necessarily the best
candidates for 3D biomarkers. This is because, the multivariate
nature of the data makes the transcript expression levels correlated
with each other, which means each of the variables (cytokine
transcript expression levels in our case) can be represented by a
group of other variables. Other cytokines may have the same or
similar statistical power of these 16 cytokines to discriminate 2D
from 3D, with better biological meanings. For this reason,
cytokines significantly up-regulated in 3D and NS culture
conditions were examined in detail.
3.3 Cytokines up-regulated in 3D and NS
In Tables S1 and S2, we present cytokine significantly up-
regulated (p#0.05) in 3D and NS cultures. Forty and ninety-one
probesets were up-regulated in 3D and NS culture conditions,
respectively. The higher number in NS cultures is possibly due to
inability to control the size of neurospheres. Many NS were
observed to be larger than the 3D structure pore sizes (e.g., three
times the maximum pore size of 100 mm) [13]. With large NS, the
core of the cellular aggregate may experience hypoxia to the
extent that genes not observed in 3D are up-regulated. Evidence in
Table 1. Classification of samples by linear discrimination analysis after cross-validation with 681cutokine probesets.
From Number of samples classified to Total Error
2D 3D
2D 7 1 8 12.5%
3D 2 8 10 20%
Total 9 9 18 16.25%
From Number of samples classified to
A2D A3D B2D B3D NS
A 2 D40000 40
A 3 D12000 33 3 . 3 3 %
B 2 D00310 42 5 %
B 3 D00210 36 6 . 6 7 %
N S 00004 40
Total 5 2 5 2 4 18 25%
doi:10.1371/journal.pone.0026821.t001
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induced by hypoxia [21] that was also found to be up-regulated in
NS but not in 3D conditions in our study. Table 3 lists 13 genes
(ANGTL7/CDT6, ARMET/MANF, BMP8B/OP2, CCL13/
MCP-4, FGF5, GHRL, IL-11, IL-1B/IL-1F2, NOV/IBP-9,
PDGFB, STC1, TGFA, and VEGF-A), whose transcripts were
up-regulated in both 3D and NS culture conditions, and examples
of their functions. We particularly focused on these genes in the
following physiologic function discussion because they were less
likely to be up-regulated because of conditions like hypoxia that
may be present in NS but absent in 3D conditions.
Discussion
Consistent with our results, up-regulation of cytokines in 3D
cultures compared to 2D has been reported by several transcrip-
tomic studies using cells from the four main tissue types (nerve,
muscle, connective, and epithelial) cultured in a wide variety of
platforms. For example, Klapperich and Bertozzi [19] showed that
seven cytokines (IL-8, CXCL1, CXCL2, CXCL3, CXCL5,
VEGF, LIF) were up-regulated in human fetal lung fibroblasts
(IMR-90) cultured in a collagen–glycosaminoglycan (collagen/
GAG) 3D mesh when compared to 2D surfaces. Also, up-
regulation of six cytokines (CXCL1- 3, IL-8, MIP-3a, Angiopoetin
like4) by a melanoma cell line (NA8) cultured on poly-2-
hydroxyethyl methacrylate (polyHEMA) plates was reported by
Ghosh at al. [18]. Transcriptomic findings such as those in the
above examples have been further substantiated by studies at the
protein level. For example, Enzerink et al. [16] have reported
induction of chemokine (CCL2-5, CXCL1-3, CXCL8) secretion
due to clustering of cells in five different fibroblast cell lines
cultured in agarose. Also, Fischbach et al. [17] cultured tumor cells
(oral squamous cell carsinoma) in a 2D and 3D RGD-alginate
system and reported a dramatic enhancement of IL-8 levels in 3D.
Another study by the same group showed that when the same cells
were grown in Matrigel (lrBM) there was up-regulation of
cytokines when compared to 2D. This observation is of particular
importance as cells grown on Matrigel have already been shown to
produce an outcome similar to in vivo, like the formation of
mammary gland acinus and milk-like secretion into lumen [22]
proving that Matrigel can provide all the relevant microenviron-
mental factors. This suggests that the up-regulation of cytokines in
3D compared to 2D is not a random differential response but is
pertinent as a similar response is elicited when a proven
physiologically relevant microenvironmental platform is provided.
We have used the themes of tumorogenesis, inflammation and
development as shown in Table 3 to closely examine the13 up-
regulated transcripts in both 3D and NS culture conditions; cells in
a 3D culture in vitro relate to in vivo phenomenon like avascular
tumor progression, early stages of inflammatory wound healing or
embryonic development depending upon their type- malignant,
primary or stem [4]. As these conditions are regulated by
autocrine and paracrine cytokine signaling in vivo, the up-
regulation of cytokines in 3D culture is physiologically relevant.
Angiogenesis is recurrent function among the genes listed in
Table 3, which is not surprising. As already mentioned, as a
microtissue grows beyond a certain size, nutrient and oxygen
depletion become limiting factors leading to the inhibition of cell
proliferation and initiation of angiogenic signaling. Oxygen
concentration in 3D tissues depends on the balance between
oxygen delivery and consumption. In vivo, this balance is tightly
regulated by evenly distributed capillary networks but in vitro
homotypic 3D microtissues lack vasculature and therefore develop
a hypoxic core as their size increases. This event leads to the cells
producing chemical signals (cytokines) for angiogenesis and is quite
similar to the response occurring in normal hypoxic tissues where
balanced signaling cascades lead to vascular remodeling and
angioadaptation until the tissue oxygen concentration is back
within its normal range [23]. The up-regulation of VEGF-A and
other genes with angiogenic function like ANGPTL7/CDT6,
FGF5, NOV/IBP-9, and TGFA is pointing to a functional class of
cytokines with great potential as three-dimensionality biomarkers.
The above genes may play other roles besides being factors
involved with hypoxia induced angiogenesis. For example, VEGF-
A has been shown to regulate neuronal development, survival,
neurite growth and it also possesses gliotrophic properties. Also,
Table 2. Most influential genes in LDA Classification by stepwise selection (p,0.01).
Symbol Title P value Up regulated in:
GREM2 gremlin 2, cysteine knot superfamily, homolog (Xenopus laevis) ,.0001
STC1 stanniocalcin 1 ,.0001 3D and NS
GDF3 growth differentiation factor 3 0.0003 3D and NS
IFNA4 interferon, alpha 4 0.0008 3D and NS
NRG1 neuregulin 1 0.006
INSL5 insulin-like 5 0.007 3D and NS
GHRL Ghrelin/obestatin preprohormone 0.0012 3D and NS
LIF leukemia inhibitory factor (cholinergic differentiation factor) 0.0059 NS
PPBPL2 pro-platelet basic protein-like 2 0.0017 3D and NS
FASLG Fas ligand (TNF superfamily, member 6) 0.0041 3D and NS
CCL28 chemokine (C-C motif) ligand 28 ,.0001 3D
FGF22 fibroblast growth factor 22 0.0016 NS
UCN3 urocortin 3 (stresscopin) ,.0001 3D and NS
CXCL2 Chemokine (C-X-C motif) ligand 2 0.0032 3D and NS
IFNA7 interferon, alpha 7 ,.0001 3D and NS
EDN3 endothelin 3 0.005 3D
doi:10.1371/journal.pone.0026821.t002
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to be up-regulated in 3D cultures of a variety of cell and tissue
types including human fetal lung fibroblasts [19], oral squamous
cell carcinoma, glioblastoma, breast cancer [17], neonatal rat
cardiomyocytes and neonatal mouse cardiomyocytes [24]. This
up-regulation in a non-cell type specific manner in 3D cultures of
VEGF-A, and probably other members of the class, lends
credibility to the notion of ubiquity of these potential biomarkers
in different cells derived from different tissue types.
Another recurrent gene function theme in Table 3 is terminal
differentiation, a process by which cells commit to being part of a
particular tissue or organ and perform a particular function.
Terminal differentiation is preceded by inhibition of proliferation
and cell cycle arrest. This exerts endoplasmic reticulum stress on
the cell, but anti-apoptotic factors like Bcl-2 protect the cell from
apoptosis and commit it to differentiation. In 3D, much like in
organs in vivo, there is a spatial constraint on the microtissue,
exerted by the defined pore size of the scaffold, which prevents
Table 3. Cytokines up-regulated in both 3D and neurospheres with role examples in cells of nerve tissue origin.
Title Symbol Tumorogenesis Inflammation Development
angiopoietin-like 7/
cornea-derived
transcript 6
ANGPTL7/CDT6 Reduces tumor growth & acts
as a negative regulator of
angiogenesis in corneal cells [29].
Maintenance of corneal
avascularity [29].
arginine-rich, mutated in
early stage tumors/
mesencephalic
astrocyte-derived
neurotrophic factor
ARMET/MANF Inhibits tumor cell proliferation
under hypoxia induced ER stress
& protects tumor cells from ER
stress-induced death [30].
Protects neurons from ER stress.
Promotes neuron proliferation &
prevents apoptosis during
neuro- degeneration [31]
Expressed in developing nigro-
striatal system at P1 & P10,
suggesting a role in development
of midbrain dopaminergic
neurons [32].
Bone morphogenetic protein
8b (osteogenic protein 2)
BMP8B
chemokine (C-C motif) ligand 13 CCL13
fibroblast growth factor 5 FGF5 Oncogenic activities in astrocytic
tumours by promoting growth,
survival and migration & supporting
neoangiogenesis [33].
Regulates neuron differentiation,
survival [34], as well as astroglial
properties [35].
Ghrelin/obestatin
preprohormone
GHRL Regulates tumor proliferation [36].
interleukin 11 IL11 Neuropoietic effect on
neurons [37]. Astrocyte [38] &
neuronal differentiation [39].
interleukin 1, beta IL1B Expressed by glial cells around a
tumor that are involved in immune
reactions against the tumor & the
damage caused by it [40].
Pro-inflammatory causes neural
damage after CNS injury by
inducing nitric oxide, free
radicals & neurotoxins. Induces
astrocytes to produce GFs that
affect survival & proliferation of
oligodendrocytes [41].
Inducer of remyelination [42].
nephroblastoma
overexpressed gene
NOV Associated with tumorogenesis,
tumor differentiation,
metastasis [43] &
angiogenesis [44].
Regulates angiogenesis and
fibroblast functions during
wound healing [45].
Expressed in early stages (E3)
neuroepithelium and later stage
(E3–E7) neural tube [46]. Detected
highly in human neuronal cells
and axons [47]. Embryonic
vascular development [44].
platelet-derived growth
factor beta polypeptide
(simian sarcoma viral (v-sis)
oncogene homolog)
PDGFB Induces the formation & progression
of gliomas in neural progenitor cells.
Required to overcome cell-cell
contact inhibition and confers
in vivo infiltrating potential to
tumor cells [48].
Released by astrocytes and
neurons after injury. Important
for neuroprotection and repair
in connection with neural
disease and injury [49].
Neuronal development and
diffentiation of undifferentiated
NE cells directly to neurons [50].
Increases survival and neurite
outgrowth of fetal striatal
neurons [51].
stanniocalcin 1 STC1 Marker of human cancer.
Regulates tumor size, proliferation
& micrometastases [52].
Protects neurons from
oxidative & hypoxic
stress [53].
Regulates terminal
differentiation
of neural cells [54].
transforming growth
factor, alpha
TGFA Mitogenic for glioma cell lines.
Participates in angiogenesis of
glioma by inducing expression
of VEGF [55].
Regulates neural progenitors
proliferation/cell fate choice,
neuronal survival/differentiation,
astrocytic reactivity & has
neurotrophic effects on
neurons [56].
vascular endothelial
growth factor A
VEGFA Induces angiogenesis, promotes
cell migration & invasion potential
of glioma cells [57,58].
Role in blood-brain barrier (BBB)
breakdown and angiogenesis
after brain injury [59]. Astrocytes
in the perilesional area express
VEGF-A early after injury [60].
Shows angiogenic, blood–brain
barrier permeabilizing,
neurotrophic, gliotrophic,
and anti-apoptotic actions. [61].
doi:10.1371/journal.pone.0026821.t003
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state. Evidence in support of this comes from the fact that cells
grown in 3D have shown lower proliferation rates than their 2D
counterparts and higher expression of cyclin dependent kinase
inhibitors (CDI) p21 [25]. Also integrin mediated adhesion to the
ECM leads to activation of Bcl-2 family of genes and makes the
3D cells more resistant to apoptosis [26]. Such conditions are
favorable for the cell to undergo terminal differentiation and this
can be clearly seen by up-regulation in a number of differentiation
and survival factor in 3D and NS compared to 2D, like PDGFB
and STC1. Neural progenitor cells cultured in 3D have been
shown to differentiate and produce a heterogeneous population
consisting of neurons, astrocytes and oligodendrocytes [27]. Such
cultures essentially behave as a coculture where cells are in
symbiotic relationship with each other and might produce factors
that can modulate the functions of the other cell types. This has
been confirmed by intermediate filament glial fibrillary acidic
protein (GFAP), a marker for astrocytic differentiation that was
up-regulated in 3D and NS compared to 2D cultures (data not
shown). It is a well known fact that astrocytes play a trophic role in
supporting neurons. Factors secreted by astrocytes generally
belong to the FGF, TGF and EGF families that play an important
role in early neurogenesis [28]. Members of these families act as
potent mitogens for multipotential neural progenitors and have
been implicated in the regulation of several aspects of neurogen-
esis. Therefore up-regulation of members of these cytokine families
in 3D and NS in this study is not surprising. The identification and
validation of a few cytokines as three-dimensionality biomarkers
that are ubiquitous among cells from different tissue types needs to
be done.
Overall, cytokines gene expression results in this study support
the notion that 3D cultured cells in various formats are different
from their 2D counterparts. Furthermore, up-regulated cytokines’
transcripts, independent of culture format, have been identified;
this group of 13 cytokines commonly up-regulated in cells cultured
in polystyrene scaffolds and neurospheres are suggesting potential
for any or a combination from this list to serve as three-
dimensionality biomarkers. These results are supportive of further
cytokine identification and in vitro/in vivo validation studies with
cells from non-neural tissue.
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